Clinical Trial Update: SCT200 Plus Platinum-based Chemotherapy in Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update for SCT200 plus platinum-based chemotherapy in head and neck squamous cell carcinoma (HNSCC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Platinum-based chemotherapy (platinum-based chemotherapy)
• SCT200

Snippet

Sponsor: Sinocelltech Ltd. | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN